Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v6-EN
Language English English
Date Updated 2019-09-26 2019-08-29
Drug Identification Number 02155907 02155907
Brand name ADALAT XL - SRT 30MG ADALAT XL - SRT 30MG
Common or Proper name Nifedipine extended-release tablets Bayer Standard Nifedipine extended-release tablets Bayer Standard
Company Name BAYER INC BAYER INC
Ingredients NIFEDIPINE NIFEDIPINE
Strength(s) 30MG 30MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 28's and 98's 28's and 98's
ATC code C08CA C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-12-31 2019-09-30
Actual start date
Estimated end date 2020-01-31 2019-10-31
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments